June 2026– date –
-
Labcorp Strengthens Lipid Nanoparticle (LNP) Development as Non-Viral Vectors for Vaccine and Cell/Gene Therapy
Labcorp USA Overview Labcorp is emphasizing the crucial role of lipid nanoparticles (LNPs) as effective non-viral vectors for nucleic acid delivery in vaccines, cancer therapies, and cell and gene therapies. A key industry challenge is d... -
Drug-Free Nanoparticles Halt Aggressive Breast Cancer in Mice, Paving Way for New Therapies
The Australian Jewish News (reprinting The Times of Israel) イスラエル Overview Scientists at the Technion-Israel Institute of Technology have developed novel nanoparticles that successfully halted aggressive triple-negative breast cance... -
Argo Graphene Solutions Closes License Agreement for Grapherry’s STREAM Graphene Production Platform
Newsfile Corp. via StockTitan Canada Overview Argo Graphene Solutions Corp. has finalized a license agreement with Grapherry, Inc. for Grapherry's proprietary STREAM graphene production platform and related intellectual property. Grapher... -
Beam Therapeutics Receives FDA IND Clearance for Liver-Targeted LNP Formulation BEAM-304 for Phenylketonuria (PKU) Treatment
Beam Therapeutics USA Overview Beam Therapeutics announced FDA IND clearance for BEAM-304, a liver-targeting lipid-nanoparticle (LNP) formulation of base editing reagents, for the treatment of Phenylketonuria (PKU). Designed to correct m... -
Prinano’s Nanoimprint Lithography Breakthrough: 8-inch Photonic Chip Production at 1/10th DUV Cost, Challenging Global Incumbents
複数の報道機関 (香港NTI、Semiconductor Engineering、Loano via YouTube) China Overview Chinese startup Prinano Technology has announced the validation of volume production for 8-inch photonic chip wafers using its indigenously developed P... -
Nanotube Advantage: OCSiAl’s TUBALL Selected to Enhance Volkswagen PowerCo’s ‘Unified Cell’ Battery Platform
OCSiAl ルクセンブルク Overview OCSiAl, a global leader in single-wall carbon nanotube production, will supply its TUBALL nanotubes to PowerCo, Volkswagen Group's battery manufacturing subsidiary, for integration into its 'Unified Cell' b... -
Light-Activated Nanomaterials Achieve 99% Bacterial Reduction in Animal Studies for Antibiotic-Resistant Wound Infections
The Economic Times India Overview Scientists have developed light-activated nanomaterials that demonstrated up to 99% bacterial reduction in animal studies for antibiotic-resistant wound infections, including those with biofilms. This br... -
OCSiAl Unveils Comprehensive News Archive for Carbon Nanotube Innovations and Market Insights
OCSiAl News ルクセンブルク Overview OCSiAl has launched a new news archive page, offering a comprehensive historical resource for its carbon nanotube technology applications and corporate announcements. This platform consolidates past re... -
OCSiAl to Unveil Advanced Graphene Nanotubes at APFE 2026: Enhancing Conductivity, Thermal Performance, and Durability in Next-Gen Materials
OCSiAl Events ルクセンブルク Overview OCSiAl will showcase its cutting-edge TUBALL™ graphene nanotube technology at APFE 2026 in Shanghai from June 24-26. These single-walled carbon nanotubes significantly improve electrical conductivity... -
Sigma-Aldrich Highlights PbS Quantum Dot Photovoltaic Applications and Core/Shell QD Structure Advances: Key to Next-Gen Solar Cell Efficiency
Sigma-Aldrich USA Overview A Sigma-Aldrich technical article underscores the promise of quantum dot (QD)-based solar cells as a next-generation photovoltaic technology. It particularly focuses on the potential of PbS QDs in photovoltaic ...
